Interleukin (IL)-5 but not immunoglobulin E reconstitutes airway inflammation and airway hyperresponsiveness in IL-4-deficient mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 3, 2000, Pages 327-334

  Hamelmann, E ^a   Takeda, K ^a   Haczku, A ^a   Cieslewicz, G ^a   Shultz, L ^a   Hamid, Q ^a   Xing, Z ^a   Gauldie, J ^a   Gelfand, E W ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033834828     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.3.3796     Document Type: Article

References (50)

1. Inflammatory cells in acute and chronic asthma
2. Inflammatory processes and bronchial hyperresponsiveness
3. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
4. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
5. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
6. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures
7. Mechanism of immunoglobulin isotype switching
8. IL-4 directs the development of TH2-like helper/effectors
9. The role of adhesion molecules in human eosinophil and basophil recruitment
10. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor
11. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
12. Recombinant human interleukin 5 is a selective activator of human eosinophil function
13. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
14. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
15. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model
16. Anti-interleukin 5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
17. Attenuation of allergic airway inflammation in IL-4 deficient mice
18. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
19. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
20. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
21. Central role of IgE in the induction of lung eosinophil imfiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
22. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness
23. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
24. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
25. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
26. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific IgE and IgG1 in mice
27. An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model
28. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airway eosinophilia
29. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage
30. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
31. Development of eosinophilic airway inflammation and airway hyperresponsiveness (AHR) in allergen sensitized mast cell deficient mice
32. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice
33. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor
34. Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice
35. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores
36. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
37. Active anaphylaxis in IgE-deficient mice
38. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin
39. The role of cytokines in the development of allergen-induced airway hyperresponsiveness
40. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires IL-5 but not IgE or B cells
41. Anti-interleukin 5 but not anti-immunoglobulin E prevents airway inflammation and inhibits the development of airway hyperresponsiveness
42. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells
43. Th2 cells mediate IL-4-dependent local tissue inflammation
44. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
45. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization
46. Interleukin-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection
47. Mast cell activation enhances airway responsiveness to methacholine in the mouse
48. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
49. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration